Transplantation for Cholangiocarcinoma: When and for Whom?

Surgical Oncology Clinics of North America

Volumn 18, Issue 2, 2009, Pages 325-337

  Rea, David J ^a   Rosen, Charles B ^a   Nagorney, David M ^a   Heimbach, Julie K ^a   Gores, Gregory J ^b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chemotherapy; Cholangiocarcinoma; Liver transplantation; Neoadjuvant; Outcomes; Radiation

Indexed keywords

CAPECITABINE; FLUOROURACIL;

ADJUVANT THERAPY; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; DUODENITIS; EXTERNAL BEAM RADIOTHERAPY; GASTRITIS; HEPATIC ARTERY; HEPATOJEJUNOSTOMY; HUMAN; INCIDENCE; INTRAHEPATIC BILE DUCT; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPHADENECTOMY; PANCREATICODUODENECTOMY; PATIENT SELECTION; PORTAL VEIN; PRIMARY SCLEROSING CHOLANGITIS; RADIATION DOSE; REVIEW; STOMACH EMPTYING;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS; LIVER TRANSPLANTATION;

EID: 62549128643     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.12.008     Document Type: Review

References (27)

1. de Groen P.C., Gores G.J., LaRusso N.F., et al. Biliary tract cancers. N Engl J Med 341 18 (1999) 1368-1378
2. Shaib Y.H., Davila J.A., McGlynn K., et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol 40 3 (2004) 472-477
3. Shaib Y., and El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin Liver Dis 24 2 (2004) 115-125
4. Launois B., Campion J.P., Brissot P., et al. Carcinoma of the hepatic hilus: surgical management and the case for resection. Ann Surg 190 2 (1979) 151-157
5. Rea D.J., Munoz-Juarez M., Farnell M.B., et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139 5 (2004) 514-523 [discussion 523-5]
6. Hemming A.W., Reed A.I., Fujita S., et al. Surgical management of hilar cholangiocarcinoma. Ann Surg 241 5 (2005) 693-699 [discussion 699-702]
7. Rosen C.B., Nagorney D.M., Wiesner R.H., et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213 1 (1991) 21-25
8. Rosen C.B., and Nagorney D.M. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 11 1 (1991) 26-30
9. Goss J.A., Shackleton C.R., Farmer D.G., et al. Orthotopic liver transplantation for primary sclerosing cholangitis: a 12-year single center experience. Ann Surg 225 5 (1997) 472-481 [discussion 481-3]
10. Abu-Elmagd K.M., Malinchoc M., Dickson E.R., et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 177 4 (1993) 335-344
11. Ghali P., Marotta P.J., Yoshida E.M., et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl 11 11 (2005) 1412-1416
12. Meyer C.G., Penn I., and James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69 8 (2000) 1633-1637
13. Robles R., Figueras J., Turrion V.S., et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 239 2 (2004) 265-271
14. Becker N.S., Rodriguez J.A., Barshes N.R., et al. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 12 1 (2008) 117-122
15. Pitt H.A., Nakeeb A., Abrams R.A., et al. Perihilar cholangiocarcinoma: postoperative radiotherapy does not improve survival. Ann Surg 221 6 (1995) 788-797 [discussion 797-8]
16. McMasters K.M., Tuttle T.M., Leach S.D., et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174 6 (1997) 605-608 [discussion 608-9]
17. Alden M.E., and Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 28 4 (1994) 945-951
18. Foo M.L., Gunderson L.L., Bender C.E., et al. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 39 4 (1997) 929-935
19. Sudan D., DeRoover A., Chinnakotla S., et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2 8 (2002) 774-779
20. Gleeson F.C., Rajan E., Levy M.J., et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc 67 3 (2008) 438-443
21. De Vreede I., Steers J.L., Burch P.A., et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6 3 (2000) 309-316
22. Rea D.J., Heimbach J.K., Rosen C.B., et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242 3 (2005) 451-458 [discussion 458-61]
23. Heimbach J.K., Gores G.J., Haddock M.G., et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82 12 (2006) 1703-1707
24. Mantel H.T., Rosen C.B., Heimbach J.K., et al. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 13 10 (2007) 1372-1381
25. Gores G.J., Gish R.G., Sudan D., et al. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 12 Suppl 12 (2006) S95-S97
26. Neuhaus P., Jonas S., Bechstein W.O., et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 230 6 (1999) 808-818 [discussion 819]
27. Jonas S., Benckert C., Thelen A., et al. Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol 34 3 (2008) 263-271